Breathalyzer with Nano-Chip Diagnose for Lung Cancer

Researchers at Tel Aviv University in Israel in cooperation with foreign partners have developed an innovative device to detect lung cancer at its earliest stages.

Lung cancer is known for its high mortality percentage in comparison to other types of cancer.

The reason for this is that when you feel the pain you are most probably in the advanced stages when it has spread to other organs. Lung cancer is deadly cancer and leaves no fingerprints when attacking people.

The new device, developed by a team of Israeli, American and British researchers, can detect lung cancer at its earlier stages. Unlike other methods of diagnosis, this new development is simple and effective.

The study and testing of respiratory tubes, called “Nanose” sniff cancer tumors. One of the leading researchers who developed this device is Professor Nir Peled. The study involved 358 patients who were at risk of getting lung cancer or were diagnosed with lung cancer. Professor Nir Peled, a leading pulmonologist, oncologist at Herzliya Medical Center, describes the results of the study: “Our Nanouz revealed lung cancer with an accuracy of 90%, even in cases where the formation of the lungs was the smallest size and did not allow a biopsy. In four out of five cases the device even successfully differentiated between benign and malignant lesions in the lungs. ”

What is the mechanism of action of the new device?

The mechanism of action is a special nano-chip embedded in a conventional tube for the breath test. Lung cancers produce volatile organic compounds (VOCs) that evaporate easily and they have a specific smell. Professor Hossam Haik (one of the participants in the development of the machine) took advantage of this process and created a highly sensitive chip that can detect the smell of VOCs and determine which particular type of lung cancer is characterized by the smell. It turned out that the bigger the tumor, the more pronounced the “signature.” The test also distinguishes between advanced and early lung cancer.

Diagnosis and treatment of lung cancer in “Herzliya Medical Center”

Professor Nir Peled is known for its unique approach and humane attitude to each patient. On his initiative, “Herzliya Medical Center” has developed a fast and effective program for the early detection and the prevention of lung cancer. Professor Peled offers a diagnosis for advanced lung cancer patients at the molecular level and picks up an individual plan targeted or biologic therapy.

Lung cancer before the new device required invasive procedures such as surgery, biopsy and/or bronchoscopy; now the new device offers a new concept, using the patient’s breath for diagnosing cancer.

Professor Peled believes that within a couple of years this device will penetrate the market and save many lives. Meanwhile, the device can be plugged into a computer’s USB port.